Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6144649 | American Journal of Obstetrics and Gynecology | 2016 | 26 Pages |
Abstract
AH and LH remain the preferred routes for hysterectomy in gynecologic oncology. Over the past decade, there has been a significant shift to LH with lower 30-day readmission and complication rates. There may be a limited role for VH in select patients. Current efforts to standardize the surgical approach to hysterectomy should not apply to patients with known or suspected gynecologic cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Tiffany L. MD, Christopher B. MD, Heidi J. MD, Barbara A. MD, Renata R. MD, John B. MD, PhD,